Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and- resistant streptococci

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1838-1841

  Betriu, Carmen ^a   Redondo, Montserrat ^a   Palau, M Luisa ^a   Sánchez, Ana ^a   Gómez, María ^a   Culebras, Esther ^a   Boloix, Ana ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LINEZOLID; MIOKAMYCIN; MOXIFLOXACIN; PENICILLIN G; ROXITHROMYCIN; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG POTENCY; GENE LOCUS; HUMAN; LIVER TOXICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ACETAMIDES; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OXAZOLES; OXAZOLIDINONES; QUINOLINES; STREPTOCOCCUS; VIRGINIAMYCIN;

EID: 0033920326     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1838-1841.2000     Document Type: Article

References (30)

1. Baquero, F., J. A. García-Rodríguez, J. García-de-Lomas, L. Aguilar, and the Spanish Surveillance Group for Respiratory Pathogens. 1999. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob. Agents Chemother. 43:178-180.
2. Baquero, F., J. A. García-Rodríguez, J. García-de-Lomas, L. Aguilar, and the Spanish Surveillance Group for Respiratory Pathogens. 1999. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob. Agents. Chemother. 43:357-359.
3. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. Susceptibility to RP 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres. J. Antimicrob. Agents Chemother. 42:651-655.
4. Betriu, C., M. C. Casado, M. Gómez, A. Sánchez, M. L. Palau, and J. J. Picazo. 1999. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn. Microbiol. Infect. Dis. 33:255-260.
5. Chen, D. K., A. McGeer, J. C. de Azevedo, and D. E. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239.
6. Cornaglia, G., M. Ligozzi, A. Mazzariol, L. Masala, G. Lo Gascio, G. Orefici, and R. Fontana. 1998. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Clin. Infect. Dis. 27(Suppl. 1):587-590.
7. de Azavedo, J. C. S., R. H. Yeing, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
8. Giovanetti, E., M. P. Montanari, M. Mingoia, and P. E. Varaldo. 1999. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.
9. Ho, P.-L., T.-L. Que, D. N.-C. Tsang, T.-K. Ng, K.-H. Chow, and W.-H. Seto. 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 43:1310-1313.
10. Hsueh, P.-R., L.-J. Teng, L.-N. Lee, P.-C. Yang, S.-W. Ho, and K.-T. Luh. 1999. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. Antimicrob. Agents Chemother. 37:897-901.
11. Johnston, N. J., J. C. de Azavedo, J. D. Kellner, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426.
12. Kataja, J., P. Huovinen, M. Skurnik, the Finnish Study Group for Antimicrobial Resistance, and H. Seppälä. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
13. Liñares, J., A. G. De la Campa, and R. Pallarés. 1999. Fluoroquinolone resistance in Streptococcus pneumoniae. N. Engl. J. Med. 341:1546-1547.
14. Marchese, A., E. A. Debbia, and G. C. Shito. 1999. In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy. Clin. Microbiol. Infect. 5:488-495.
15. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed., vol. 17, no. 2. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. National Committee fur Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9. National Committee for Clinical Laboratory Standards. Wayne, Pa.
17. Nishijima, T., Y. Saito, A. Aoki, M. Toriya, Y. Toyonaga, and R. Fujii. 1999. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43:637-643.
18. Oster, P., A. Zanchi, S. Cresti, M. Lattanzi, F. Montagnani, C. Cellesi, and G. M. Rossellini. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:2510-2512.
19. Pérez-Trallero, E., M. Urbieta, M. Montes, I. Ayestaran, and J. M. Marimon. 1998. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Guipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. J. 17:25-31.
20. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
21. Seppälä, H., T. Klauka, R. Lehtonen, E. Nenonen, the Finnish Study Group for Antimicrobial Resistance, and P. Huovinen. 1995. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis. 21:1378-1385.
22. Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. H. Huovinen. 1998. A novel erythromycin methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
23. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
24. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
25. Tzelpi, E., G. Kouppari, A. Mavroidi, A. Zaphiropolou, and L. S. Tzouveleski. 1999. Erythromycin resistance amongst group A β-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J. Antimicrob. Chemother. 43:745-746.
26. Weiss, K., M. Laverdiere, and C. Restieri. 1998. Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae. J. Antimicrob. Chemother. 42:523-525.
27. Wise, R., J. M. Andrews, F. J. Boswell, and J. P. Ashby. 1998. The in vitro activity of linezolid (U-100766) and tentative breakpoints. J. Antimicrob. Chemother. 42:721-728.
28. Woodcock, J. M., J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise. 1997. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.
29. Wu, J.-J., K.-Y. Lin, P.-R. Hsueh, J.-W. Liu, H.-J. Pan, and S.-M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.
30. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kin̄burn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachin, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100776, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.